Le Lézard
Classified in: Health, Science and technology
Subject: Dividend

Agilent Technologies Announces Cash Dividend of 16.4 Cents Per Share


Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 16.4 cents per share of common stock will be paid on Oct. 23, 2019 to all shareholders of record as of the close of business on Oct. 1, 2019.

The timing and amounts of future dividends are subject to determination and approval by Agilent's board.

About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 15,500 people worldwide. Information about Agilent is available at www.agilent.com. To receive the latest Agilent news, subscribe to our Newsroom.

Follow Agilent on LinkedIn, Twitter, and Facebook.

Forward-Looking Statements

This news release contains forward-looking statements as defined in the Securities Exchange Act of 1934 and is subject to the safe harbors created therein. The forward-looking statements contained herein include, but are not limited to, information regarding the company's dividend program and future payment obligations. These forward-looking statements involve risks and uncertainties that could cause Agilent's results to differ materially from management's current expectations. Such risks and uncertainties are detailed in Agilent's filings with the Securities and Exchange Commission, including our quarterly report on Form 10-Q for the quarter ended July 31, 2019. Forward-looking statements are based on the beliefs and assumptions of Agilent's management and on currently available information. Agilent undertakes no responsibility to publicly update or revise any forward-looking statement.


These press releases may also interest you

at 04:35
Caranx Medical (?Caranx'), a French medical device company specializing in the development of autonomous robot to democratize access to Transcatheter Aortic Valve Implantation (TAVI), a lifesaving procedure, today announced the successful world first...

at 04:35
Human Pharma sales up 10.3%* to EUR 20.8 bn, driven by JARDIANCE® and OFEV®Animal Health sales up 6.9 %* to EUR 4.7 bn, fueled by new product launchesR&D expenditures increase by 14.2% to EUR 5.8 bn Boehringer Ingelheim today...

at 04:04
NaturVet, the 30-year pioneer and present-day innovator of the pet health and wellness industry, announces the latest innovation in the pet supplement realm: Breed Specific Soft Chews®. This new comprehensive line is made up of five products that...

at 04:01
Bizrahmed, a leading cosmetic center in Dubai, is delighted to announce the joining of internationally acclaimed British plastic surgeon, Mr. Norman Waterhouse. This strategic collaboration is set to be significant, as it boots the range of cosmetic...

at 04:00
Slone Partners, a nationwide executive search firm for life sciences, healthcare, and nonprofit and social impact organizations, has announced the placement of Chris A. Raanes as Chief Executive Officer (CEO) at Magnetic Insight, the global leader in...

at 03:05
MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clinical trial with MH002 in the orphan disease...



News published on and distributed by: